Alternative Green Tea

Note
Integrative therapies should not replace antiretroviral therapy (ART) in HIV patients. Patients should consult their healthcare providers before taking any herbs or supplements because they may interact with treatment. In particular, patients should not take St.John’s wort because it may interact with HIV treatment.

Unclear or conflicting scientific evidence

Green tea

Green tea is made from the dried leaves of Camellia sinensis, a perennial evergreen shrub. Green tea has a long history of use, dating back to China approximately 5,000 years ago. Green tea, black tea, and oolong tea are all derived from the same plant.
Preliminary research suggests that green tea may decrease viral load in carriers of the human T-cell lymphocytic virus.

Additional well-designed controlled research is needed before a conclusion can be made.

  • Avoid if allergic or hypersensitive to caffeine or tannins.
  • Use cautiously with diabetes or liver disease.
  • Selected References
    AIDS.org. www.aids.org. Accessed March 29, 2009.
    American Foundation for AIDS Research (amfAR). www.amfar.org. Accessed March 29, 2009.
    Centers for Disease Control and Prevention (CDC). www.cdc.gov. Accessed March 29, 2009.
    Elizabeth Glaser Pediatric AIDS Foundation. www.pedaids.org. Accessed March 29, 2009.
    Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground on preventing sexual transmission of HIV.Lancet. 2004 Nov 27-Dec 3;364(9449):1913-5.
    Loutfy MR, Antoniou T, Shen S, et al. Virologic and immunologic impact and durability of enfuvirtide-basedantiretroviraltherapy in HIV-infected treatment-experienced patients in a clinical setting. HIV Clin Trials.
    2007Jan-Feb;8(1):36-44.
    National Institute of Allergy and Infectious Diseases (NIAD). www.niaid.nih.gov. Accessed March 29, 2009.
    Natural Standard: The Authority on Integrative Medicine. www.naturalstandard.com. Copyright © 2009. Accessed March 29, 2009.
    Rigopoulos D, Gregoriou S, Paparizos V, et al. AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues. Skinmed. 2007 Mar-Apr;6(2):79-84.
    The Body: The Complete HIV/AIDS Resource. www.thebody.com. Accessed March 29, 2009.
    U.S. Food and Drug Administration (FDA). www.fda.gov. Accessed March 29, 2009.
    Vrouenraets SM, Wit FW, van Tongeren J, et al. Efavirenz: a review. Expert Opin Pharmacother. 2007 Apr;8(6):851-71.